Nuformix (LON:NFX) Reaches New 52-Week Low – What’s Next?

by · The Markets Daily

Nuformix plc (LON:NFX – Get Free Report)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.06 ($0.00), with a volume of 14691373 shares trading hands. The stock had previously closed at GBX 0.06 ($0.00).

Nuformix Price Performance

The company has a market capitalization of £491,586.00, a PE ratio of -1.63 and a beta of 1.22. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 3.35. The company’s 50 day simple moving average is GBX 0.13 and its 200 day simple moving average is GBX 0.17.

Nuformix Company Profile

(Get Free Report)

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.

See Also